Delivery Order SPE2DB20D7061-SPE2DB25FSPP1
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,113.89 to AmerisourceBergen Drug Corp for the supply of Sevelamer HCL 800 mg tablets (180-count) on July 23, 2025, with completion expected by July 24, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The U.S. Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Sevelamer Carbonate 800 mg tablets (270-count). This is a firm fixed-price delivery order with a ceiling value of $5,849.30, with an ultimate completion date of August 21, 2025. The contract represents a non-competitive, non-set-aside award, and the place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a leading global pharmaceutical distribution company. The contract is for the supply of Sevelamer Carbonate 800 mg tablets, a medication used to treat high phosphorus levels in patients with chronic kidney disease. The contract has a ceiling value of $1,236.22 and a period of performance through March 27, 2024. This delivery order is part of a larger indefinite...
- This contract award to AmerisourceBergen Drug Corp's Corporate Office Division provides for the delivery of sevelamer carbonate 800 mg tablets to the Department of Defense's Medical Supply Chain (DLA Troop Support Medical). The $2,192.13 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract valued at up to $999,999,999 through December 2025 for pharmaceutical and medical supplies. This contract does not have a set-aside designation. AmerisourceBergen, one of the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,158.43, is for the supply of sevelamer carbonate 800 mg tablets. The contract has an ultimate completion date of January 8, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp Corporate Office Division. The $2,408.53 firm-fixed-price contract is for the delivery of 4565192317 - Sevelamer 0.8 GM Powder Packets, 90 count. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $631.78 delivery order against the Defense Logistics Agency's prime vendor contract to provide 4561462497 SEVELAMER CARBONATE 800 MG tablets. The firm fixed price order calls for delivery of 90 tablets to a location in Conshohocken, Pennsylvania, with performance required between July 11-12, 2023. No set aside designation or subcontracting details were provided. The Defense Logistics Agency...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $1,890.00, is for the supply of 4,567,005,600 packets of 0.8 gram sevelamer powder. The award has no set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal...
- The Defense Logistics Agency awarded a $2,703.46 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Sacubitril-Valsartan 24-26 mg tablets (60-count). This is a non-set-aside, competitively awarded contract with an ultimate completion date of August 5, 2025, and performance location in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction typical of AmerisourceBergen's ongoing pharmaceutical supply operations...
- The Defense Logistics Agency awarded a delivery order valued at $8,139.90 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 320-25 mg tablets (90-count) on September 8, 2025, with an ultimate completion date of September 9, 2025. This competitively awarded, firm fixed-price delivery order is non-set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The order represents a single transaction under AmerisourceBergen Drug Corp's existing contract...
- SPE2DB20D7061Indefinite Delivery Contract
- SPE2DB20D7061-SPE2DB25FSPP1Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Sevelamer HCL 800 mg tablets (180-count) with a contract ceiling value of $6,710.88. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is set for ultimate completion by September 9, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency. The company maintains an extensive portfolio of pharmaceutical products and medical supplies across multiple therapeutic domains, ranging from specialty medications to vaccines and medical devices. Sevelamer HCL is a phosphate binder medication commonly used in the treatment of hyperphosphatemia in patients with chronic kidney disease, representing routine pharmaceutical supply support to federal healthcare programs. The contractor's performance under this delivery order contributes to the Defense Health Agency's pharmaceutical supply chain and the broader DLA Troop Support Medical mission of providing essential medical commodities to military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.7k | 9/8/25 |